Gross electrolyte disturbances including hypokalaemia, hypomagnesaemia, hypocalcaemia, and alkalosis have developed in tuberculous patients who were being treated with capreomycin. Similar abnormalities have also occurred when the drug gentamicin was used and were found to be due to secondary hyperaldosteronism. In this paper a detailed description of the changes induced by capreomycin is given. The evidence available strongly suggests a similar aetiology for the biochemical changes, but the precise pathophysiology is unknown. Caution should be exercised when capreomycin is used and the drug should be withdrawn if any of these abnormalities develop.
Gross electrolyte disturbances including hypokalaemia, hypomagnesaemia, hypocalcaemia, and alkalosis have developed in tuberculous patients who were being treated with capreomycin. Similar abnormalities have also occurred when the drug gentamicin was used and were found to be due to secondary hyperaldosteronism. In this paper a detailed description of the changes induced by capreomycin is given. The evidence available strongly suggests a similar aetiology for the biochemical changes, but the precise pathophysiology is unknown. Caution should be exercised when capreomycin is used and the drug should be withdrawn if any of these abnormalities develop.
Hypokalaemia, hypomagnesaemia, and alkalosis, which developed in patients treated with gentamicin for pulmonary tuberculosis, were shown to be due to a drug-induced secondary hyperaldosteronism (Holmes, Hesling, and Wilson, 1970) . Similar biochemical abnormalities have developed in 3 out of 67 tuberculous patients who were being given capreomycin (Table I) (Wilson, 1967;  4-2±0-6
The duration of disease in the control patients varied from a few weeks to many years. The disease was confined to the lungs, none had anorexia, diarrhoea or had been treated with diuretics, gentamicin, viomycin or capreomycin. Hesling, 1969; Citron, 1969) The evidence so far available suggests that drug-induced secondary hyperaldosteronism may also be responsible for these changes. This paper gives details of three patients in whom abnormalities developed during the course of therapy with capreomycin.
METHODS
The patient, admitted to the Metabolic Ward, received a self-selected constant diet which approximated closely to her previous food intake. Conventional metabolic techniques established in the laboratory were used (Stanbury and Lumb, 1962 (Fig. 1) . During the first six post-operative days her oral daily fluid intake had been about 500 ml. of milk and fruit juice and an intravenous infusion of 5% dextrose in 1/5 normal saline had contributed a daily sodium intake of 30 mEq. Table I . The plasma 17-hydroxycorticosteroids were normal. The urinary electrolytes are given as mEq/litre because a full 24 hours urine could not be collected before therapy with potassium chloride was begun. The urinary sodium was 13 mEq/ litre; potassium 109 mEq/litre; chloride 46 mEq/ litre; magnesium 9-1 mg./litre, and calcium 28 mg./ litre. Measurements of the osmolality of specimens of serum and urine which were obtained simultaneously were 247 and 399 m.osmols/litre respectively. There was no proteinuria, no aminoaciduria, and the creatinine clearance was 50 ml./minute. It was thought that patient 3 was depleted of both potassium and magnesium, but it was more difficult to account for the hyponatraemia and disparate serum and urine osmolalities. Because of the possibility of an inappropriate secretion of antidiuretic hormone, vide infra, her fluid intake was restricted to 500 ml. daily for the next three days and she was transferred to the Manchester Royal Infirmary for further investigation.
She was a small woman (weight 44 kg.), and was given a self-selected constant diet which contained by analysis 72 mEq sodium, 72 mEq chloride, 62 mEq A. M. Holmes, C. M. Hesling, and T. M. Wilson potassium, 10-4 g. nitrogen, 178 mg. magnesium, 374 mg. calcium, and 900 mg. phosphorus per day. A supplement of 240 mEq of potassium as the chloride was given daily. By 2 February the serum potassium had risen to 55 mEq/litre (Fig. 2) and the supplement was stopped. Three days later the serum potassium had fallen to 2-9 mEq/litre and a further daily supplement of 167 mEq was given until 18 February. Between 6 and 18 February a total of 470 mEq of potassium had been retained and the serum potassium had risen to 4-6 mEq/litre. The potassium supplement was again stopped and the serum potassium values subsequently remained normal. . During the period of quantitative metabolic study 780 mg. of magnesium was retained and the serum magnesium rose from 0 9 mg./100 ml. to 1-7 mg./ 100 ml. Tihe serum calcium rose concurrently from 8-0 to 9 4 mg./ 100 ml. despite the patient being 2 5 g. in negative calcium balance.
The patient on admission showed no clinical signs of sodium deficiency, but the serum sodium was 125 mEq/litre. Restriction of oral fluids to 500 ml. daily caused a rise in the serum sodium to 140 mEq/litre, but when tested on 18 February she was able to excrete a 2-litre water load normally.
The hyponatraemia was associated with a low urinary sodium (13 mEq/litre) and with a rise in plasma renin (60 units/litre on 30 January 1969), though the expected plasma renin level for the sixth postoperative day is not known. When she was given an intravenous infusion of 300 mEq sodium chloride most of this was excreted in the urine (Fig. 2) , but a cumulative retention of 560 mEq was recorded over the 30-day period of balance. The plasma renin had fallen to 14 units/litre by 18 February. There had been no change in body weight or blood pressure.
DISCUSSION
The principal biochemical features of the syndrome which developed in these three patients were hypokalaemia, hypomagnesaemia, hypocalcaemia, and a hypochloraemic extracellular alkalosis. All three had been taking a combination of capreomycin, ethambutol, and isoniazid for 22, 6, and 26 months respectively. Ethambutol and isoniazid have been used widely for the treatment of pulmonary tuberculosis and side-effects similar to those described have not been reported. Capreomycin is known to produce renal tubular damage when given in large doses to laboratory animals (Welles, Harris, Small, Worth, and Anderson, 1966 ). Yue and Cohen (1966) reported the development of acute tubular necrosis in a woman who had had four weeks' treatment with capreomycin, and Miller, Popplewell, Landwehr, and Greene (1966) found some elevation of the blood urea nitrogen in 8 of 300 patients given the drug.
The biochemical changes occurring in these patients are strikingly similar to those previously reported in patients treated with gentamicin (Holmes et al., 1970) and with viomycin (Werner, Tompsett, Muschenheim, and McDermott, 1951) . In the patients treated with gentamicin the syndrome was considered to be due to a drug-induced secondary hyperaldosteronism causing urinary loss of potassium and magnesium.
Magnesium deficiency impairs the capacity of parathyroid hormone to raise the serum calcium (Estep, Shaw, Watlington, Hobe, Holland, and Tucker, 1968; Shils, 1969) . The low serum calcium levels found in these patients may have reflected a failure of response of the bones to parathyroid hormone as a result of depletion of magnesium.
We have no definitive measurements of the plasma aldosterone levels in our patients, but an elevated plasma renin of 60 units/litre was found in patient 3 at a time when the biochemical features of hyperaldosteronism were seen. We think it unlikely that this considerable elevation in plasma renin could be explained by the surgery alone. It seems likely that these patients had also developed a state of secondary aldosteronism.
In patient 3 the initially low serum sodium values could have been due either to an inappropriate secretion of antidiuretic hornone or to sodium depletion. Inappropriate secretion of antidiuretic hormone has been found both postoperatively (Moran, Miltenberger, Shuayb, and Zimmermann, 1964; Deutsch, Goldberg, and Dripps, 1966) and in patients with pulmonary tuberculosis (Weiss and Katz, 1965) . This is, however, associated with a low aldosterone secretion rate (Turin, Cooke, and Walker, 1968) , whereas the plasma renin was elevated in patient 3, and when tested she was able to excrete a water load normally.
The low urinary sodium, high plasma renin, and retention of 560 mEq sodium during the balance period would point towards the secondary hyperaldosteronism being the result of sodium depletion, but with the evidence available it is not possible for us to be dogmatic about the precise way in which the condition is produced. We have given much thought to the possible role of renal tubular damage-there was no proteinuria, phosphaturia, glycosuria or abnormal aminoaciduriaand have found no evidence to suggest a primary tubular effect. This is not to say that capreomycin might not have a direct toxic effect on the renal tubules, but merely that we have no evidence to support this. The drug could directly stimulate the juxtaglomerular cells, but we are unaware of this having occurred in other situations.
When prolonged capreomycin therapy is necessary for the treatment of patients with pulmonary tuberculosis we would recommend that monthly estimations of the serum electrolytes are made and that the drug is stopped should hypokalaemia or hypomagnesaemia develop.
